SPINAL MUSCULAR ATROPHY TYPE II
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE II explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE II trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Horse power: new therapy hopes to improve movement in SMA children
Symptom relief Not yet recruitingThis study tests whether a special type of horseback physiotherapy can improve movement, posture, breathing, and quality of life in children with spinal muscular atrophy (SMA). Twenty children aged 2 to 9 years will receive both the horse therapy and standard physiotherapy in ran…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE II
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New study tracks Risdiplam's Real-World impact on spinal muscle atrophy
Knowledge-focused Not yet recruitingThis study will observe 30 children with type I or type II spinal muscle atrophy who are taking risdiplam. Researchers will track motor function improvements over 24 months using standard tests. The goal is to see how well the drug works in everyday medical practice.
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE II
Sponsor: Hoffmann-La Roche • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC